Does DEUCRAVACITINIB Cause Therapy non-responder? 15 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Therapy non-responder have been filed in association with DEUCRAVACITINIB (SOTYKTU). This represents 0.6% of all adverse event reports for DEUCRAVACITINIB.
15
Reports of Therapy non-responder with DEUCRAVACITINIB
0.6%
of all DEUCRAVACITINIB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Therapy non-responder From DEUCRAVACITINIB?
Of the 15 reports, 1 (6.7%) required hospitalization.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEUCRAVACITINIB. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does DEUCRAVACITINIB Cause?
Drug ineffective (228)
Acne (225)
Pruritus (187)
Rash (175)
Erythema (124)
Psoriasis (122)
Off label use (101)
Adverse event (74)
Mouth ulceration (72)
Folliculitis (65)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which DEUCRAVACITINIB Alternatives Have Lower Therapy non-responder Risk?
DEUCRAVACITINIB vs DEUTETRABENAZINE
DEUCRAVACITINIB vs DEUTIVACAFTOR\TEZACAFTOR\VANZACAFTOR
DEUCRAVACITINIB vs DEVICE
DEUCRAVACITINIB vs DEXAMETHASONE
DEUCRAVACITINIB vs DEXAMETHASONE\DEXAMETHASONE